Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 2/2011

01.02.2011 | General Gynecology

Uterine fibroids: risk of recurrence after myomectomy in a Nigerian population

verfasst von: Jesse Y. Obed, Babagana Bako, Joshua D. Usman, Joel Y. Moruppa, Saidu Kadas

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine the recurrence rate and risk factors for recurrence following myomectomy.

Methods

Two hundred and thirty-two women who had open myomectomy were followed up for 3–10 years. Clinical features as well as pelvic ultrasound scan were used to evaluate the patients for recurrence. Recurrence rate was computed and the risk factors for recurrence were determined using Odd ratio comparing the Sociodemographic characteristics, preoperative symptoms, surgical and pathologic findings in the two groups of patients.

Results

The mean age and parity of the patients were 29.3 ± 3.8 years and 1.2 ± 1.1, respectively. The desire for procreation after surgery was noted in 183 (78.9%) of the patients while the rest desired resolution of symptoms. More than half of the patients had multiple symptoms. Intraoperatively, 63 (7.2%) had single fibroid removed while the rest were multiple varying from 2 to 67 pieces. The overall recurrence rate during the follow-up period was 20.7% (48/232) at 10 years and this increases with time. Positive family history of uterine fibroids, multiple uterine fibroids, and persistence or recurrence of three or more of the pre-myomectomy symptoms were significantly associated with the recurrence of uterine fibroids (OR = 21.83, 3.14, and 3.49, respectively) while pregnancy after myomectomy and the use of oral contraceptive pills (OCP) were protective.

Conclusion

There is a high recurrence of uterine fibroid after myomectomy in our environment. The risk is higher among women with positive family history, multiple uterine fibroids, and in those with multiple symptoms. Pregnancy and use of OCP are protective.
Literatur
1.
Zurück zum Zitat Ligon AH, Morton CC (2000) Genetics of uterine leiomyomata. Genes Chromosomes Cancer 28(3):235–245CrossRefPubMed Ligon AH, Morton CC (2000) Genetics of uterine leiomyomata. Genes Chromosomes Cancer 28(3):235–245CrossRefPubMed
2.
Zurück zum Zitat Akinyemi BO, Adewoye BR, Fakoya TA (2004) Uterine fibroid: a review. Niger J Med 13(4):318–329PubMed Akinyemi BO, Adewoye BR, Fakoya TA (2004) Uterine fibroid: a review. Niger J Med 13(4):318–329PubMed
3.
Zurück zum Zitat Okezie O, Ezegwui HU (2006) Management of uterine fibroids in Enugu, Nigeria. J Obstet Gynaecol 26(4):363–365CrossRefPubMed Okezie O, Ezegwui HU (2006) Management of uterine fibroids in Enugu, Nigeria. J Obstet Gynaecol 26(4):363–365CrossRefPubMed
4.
Zurück zum Zitat Aboyeyi AP, Ijaiya MA (2002) Uterine fibroids: a ten year clinical review in Ilorin, Nigeria. Niger J Med 11(1):16–19 Aboyeyi AP, Ijaiya MA (2002) Uterine fibroids: a ten year clinical review in Ilorin, Nigeria. Niger J Med 11(1):16–19
5.
Zurück zum Zitat Emembolu JO (1987) Uterine fibromyomata: presentation and management in Northern Nigeria. Int J Gynaecol Obstet 25:413–416CrossRefPubMed Emembolu JO (1987) Uterine fibromyomata: presentation and management in Northern Nigeria. Int J Gynaecol Obstet 25:413–416CrossRefPubMed
6.
Zurück zum Zitat Stewart EA, Faur AV, Wise LA, Reilly RJ, Harlow BL (2002) Predictors of subsequent surgery for uterine leiomyomata after abdominal myomectomy. Obstet Gynaecol 99:426–432CrossRef Stewart EA, Faur AV, Wise LA, Reilly RJ, Harlow BL (2002) Predictors of subsequent surgery for uterine leiomyomata after abdominal myomectomy. Obstet Gynaecol 99:426–432CrossRef
7.
Zurück zum Zitat Reed SD, Newton KM, Thompson LB, McCrummen BA, Warolin AK (2006) The incidence of repeat uterine surgery following myomectomy. J Womens Health 15(9):1046–1052CrossRef Reed SD, Newton KM, Thompson LB, McCrummen BA, Warolin AK (2006) The incidence of repeat uterine surgery following myomectomy. J Womens Health 15(9):1046–1052CrossRef
8.
Zurück zum Zitat Hanafi M (2005) Predictors of leiomyoma recurrence after myomectomy. Obstet Gynaecol 105(4):877–881CrossRef Hanafi M (2005) Predictors of leiomyoma recurrence after myomectomy. Obstet Gynaecol 105(4):877–881CrossRef
9.
Zurück zum Zitat Fauconnier A, Chapron C, Babaki-Fard K, Dubuisson JB (2000) Recurrence of leiomyomata after myomectomy. Hum Reprod Update 6(6):595–602CrossRefPubMed Fauconnier A, Chapron C, Babaki-Fard K, Dubuisson JB (2000) Recurrence of leiomyomata after myomectomy. Hum Reprod Update 6(6):595–602CrossRefPubMed
10.
Zurück zum Zitat Candiani GB, Fedele L, Parazzini F, Villa L (1991) Risk of recurrence after myomectomy. Br J Obstet Gynaecol 98(4):385–389CrossRefPubMed Candiani GB, Fedele L, Parazzini F, Villa L (1991) Risk of recurrence after myomectomy. Br J Obstet Gynaecol 98(4):385–389CrossRefPubMed
11.
Zurück zum Zitat Fedele L, Parazzini F, Luchini L, Mezzopane R, Tozzi L, Villa L (1995) Recurrence of fibroids after myomectomy: a transvaginal ultrasonographic study. Hum Reprod 10:1795–1796PubMed Fedele L, Parazzini F, Luchini L, Mezzopane R, Tozzi L, Villa L (1995) Recurrence of fibroids after myomectomy: a transvaginal ultrasonographic study. Hum Reprod 10:1795–1796PubMed
12.
Zurück zum Zitat Crammer SF, Patel A (1990) The frequency of uterine leiomyomas. Am J Clin Pathol 94:435–438 Crammer SF, Patel A (1990) The frequency of uterine leiomyomas. Am J Clin Pathol 94:435–438
13.
Zurück zum Zitat Buttram VC, Reiter R (1981) Uterine leiomyomata: aetiology, symptomatology and management. Fertil Steril 36:433–445PubMed Buttram VC, Reiter R (1981) Uterine leiomyomata: aetiology, symptomatology and management. Fertil Steril 36:433–445PubMed
14.
Zurück zum Zitat Fedele L, Vercellini P, Bianchi S, Brioschi D, Dorta M (1990) Treatment with GnRH agonists before myomectomy and the risk of short-term myoma recurrence. Br J Obstet Gynaecol 97:393–396CrossRefPubMed Fedele L, Vercellini P, Bianchi S, Brioschi D, Dorta M (1990) Treatment with GnRH agonists before myomectomy and the risk of short-term myoma recurrence. Br J Obstet Gynaecol 97:393–396CrossRefPubMed
15.
Zurück zum Zitat Rein MS, Freidman AJ, Babieri RL, Pavelka K, Fletcher JA, Morton CC (1991) Cytogenetic abnormalities in uterine leiomyomata. Obstet Gynaecol 77:923–926 Rein MS, Freidman AJ, Babieri RL, Pavelka K, Fletcher JA, Morton CC (1991) Cytogenetic abnormalities in uterine leiomyomata. Obstet Gynaecol 77:923–926
16.
Zurück zum Zitat Rice JP, Kay HH, Mahoney BS (1989) The clinical significance of uterine leiomyomas in pregnancy. Am J Obstet Gynaecol 160:212–216 Rice JP, Kay HH, Mahoney BS (1989) The clinical significance of uterine leiomyomas in pregnancy. Am J Obstet Gynaecol 160:212–216
17.
Zurück zum Zitat Benediktsdottir S, Giersson RT (2001) Oral contraceptives and uterine fibroids. Gynaecol Forum 6(2):5–7 Benediktsdottir S, Giersson RT (2001) Oral contraceptives and uterine fibroids. Gynaecol Forum 6(2):5–7
18.
Zurück zum Zitat Kurbanova M, Koroleva AG, Sergeev AS (1989) Genetic-epidemiological analysis of uterine myoma: estimate of risk to relatives. Genetika 25:1896–1898PubMed Kurbanova M, Koroleva AG, Sergeev AS (1989) Genetic-epidemiological analysis of uterine myoma: estimate of risk to relatives. Genetika 25:1896–1898PubMed
19.
Zurück zum Zitat Vikhlyaeva EM, Khodzhaeva ZS, Fantschenko ND (1995) Familial predisposition to uterine leiomyomas. Int J Gynaecol Obstet 51:127–131CrossRefPubMed Vikhlyaeva EM, Khodzhaeva ZS, Fantschenko ND (1995) Familial predisposition to uterine leiomyomas. Int J Gynaecol Obstet 51:127–131CrossRefPubMed
20.
Zurück zum Zitat Marhall LM, Spiegelman D, Barbieri RL, Goldman MB, Manson JE, Colditz GA (1998) Variation of the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynaecol 90:967–973CrossRef Marhall LM, Spiegelman D, Barbieri RL, Goldman MB, Manson JE, Colditz GA (1998) Variation of the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynaecol 90:967–973CrossRef
Metadaten
Titel
Uterine fibroids: risk of recurrence after myomectomy in a Nigerian population
verfasst von
Jesse Y. Obed
Babagana Bako
Joshua D. Usman
Joel Y. Moruppa
Saidu Kadas
Publikationsdatum
01.02.2011
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 2/2011
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-010-1355-y

Weitere Artikel der Ausgabe 2/2011

Archives of Gynecology and Obstetrics 2/2011 Zur Ausgabe

Ambulantisierung: Erste Erfahrungen mit dem Hybrid-DRG

02.05.2024 DCK 2024 Kongressbericht

Die Hybrid-DRG-Verordnung soll dazu führen, dass mehr chirurgische Eingriffe ambulant durchgeführt werden, wie es in anderen Ländern schon länger üblich ist. Die gleiche Vergütung im ambulanten und stationären Sektor hatten Niedergelassene schon lange gefordert. Aber die Umsetzung bereitet ihnen doch Kopfzerbrechen.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Harninkontinenz: Netz-Op. erfordert über lange Zeit intensive Nachsorge

30.04.2024 Harninkontinenz Nachrichten

Frauen mit Belastungsinkontinenz oder Organprolaps sind nach einer Netz-Operation keineswegs beschwerdefrei. Vielmehr scheint die Krankheitslast weiterhin hoch zu sein, sogar höher als von harninkontinenten Frauen, die sich nicht haben operieren lassen.

Welche Übungen helfen gegen Diastase recti abdominis?

30.04.2024 Schwangerenvorsorge Nachrichten

Die Autorinnen und Autoren einer aktuellen Studie aus Griechenland sind sich einig, dass Bewegungstherapie, einschließlich Übungen zur Stärkung der Bauchmuskulatur und zur Stabilisierung des Rumpfes, eine Diastase recti abdominis postpartum wirksam reduzieren kann. Doch vieles ist noch nicht eindeutig belegt.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.